Autoantibodies could shape cancer risk, growth and response to immunotherapy

Дата публикации: 25-07-2026 20:00:03

Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests a commentary published in Cell co-authored by a team that includes Jean-Laurent Casanova, M.D., Ph.D., a professor in the Center for the Genetics of Host Defense and Children's Medical Center Research Institute at UT Southwestern (CRI).

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Abnormal antibodies that disrupt DNA repair could explain childhood cancer	0	5.41	14-10-2026
2	Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells	0	8.03	24-07-2026
3	Inherited gene variants may shape CAR-T therapy benefits and toxic side effects	0	8.44	24-07-2026
4	El descubrimiento inesperado de anticuerpos anormales podría explicar el cáncer infantil	0	5.47	14-10-2026
5	Эксперт Баранова: вакцинация от COVID-19 снизила риски аутоиммунных заболеваний	0	0	16-07-2025
6	В России выявили генетические маркеры редкого аутоиммунного заболевания ​​	5	7	30-06-2026
7	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
8	Key gut protein balances immune protection and tolerance	6	7	07-07-2026
9	Obesity promotes lung cancer by suppressing immune response, study shows	0	8	08-07-2026
10	Гинцбург: иммунодепрессанты могут влиять на эффективность вакцины от коронавируса	0	0	11-11-2020

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.66. Источник: medicalxpress.com.